NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.16% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 1.83% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.80% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.79% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.75% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.73% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.70% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.69% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.66% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.66% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.66% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.63% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 1.62% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.59% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.58% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.44% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.39% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.32% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.29% |